A retrospective study of venetoclax‐based regimens in patients with relapsed/refractory multiple myeloma
Latest Information Update: 08 Feb 2021
At a glance
- Drugs Bortezomib (Primary) ; Carfilzomib (Primary) ; Daratumumab (Primary) ; Dexamethasone (Primary) ; Venetoclax (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 08 Feb 2021 New trial record